Search Tag: revenue growth
2024 31 Jul
Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2024 ended June 30, 2024. Q3 Fiscal Year 2024 Good equipment book-to-bill ratio of 1.07 further increases already high order backlog Comparable revenue growth of 4.3% against a very strong prior-year quarter (10.1% excluding rapid COVID-19 antigen...Read more
2024 31 Jul
Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2024 ended June 30, 2024. Q3 Fiscal Year 2024 Good equipment book-to-bill ratio of 1.07 further increases already high order backlog Comparable revenue growth of 4.3% against a very strong prior-year quarter (10.1% excluding rapid COVID-19 antigen...Read more
2024 23 Jul
The healthcare industry has faced significant profitability challenges over the past decade, with these difficulties intensifying since the COVID-19 pandemic. This financial strain has hindered organisations in their mission to deliver innovative, high-quality, equitable, and affordable care. Healthcare finance leaders have traditionally focused...Read more
2024 23 Jul
The healthcare industry has faced significant profitability challenges over the past decade, with these difficulties intensifying since the COVID-19 pandemic. This financial strain has hindered organisations in their mission to deliver innovative, high-quality, equitable, and affordable care. Healthcare finance leaders have traditionally focused...Read more
2024 21 May
Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future of medicine and drive long-term growth Decoupling carbon emissions from revenue growth AstraZeneca revealed its bold ambition to deliver...Read more
2024 21 May
Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future of medicine and drive long-term growth Decoupling carbon emissions from revenue growth AstraZeneca revealed its bold ambition to deliver...Read more
2024 07 May
Siemens Healthineers AG announces its results for the second quarter of fiscal year 2024 ended March 31, 2024. Q2 Fiscal Year 2024 Good equipment book-to-bill ratio of 1.08 Comparable revenue growth of 3.0% against a very good prior-year quarter (excluding rapid COVID-19 antigen tests, growth of 11.7%) Imaging comparable revenue...Read more